Takeda Pharmaceutical (TAK) Goodwill (2017 - 2026)

Takeda Pharmaceutical's Goodwill history runs 10 years deep, the most recent figure standing at $37.0 billion for Q1 2026.

• In Q1 2026, Goodwill rose 6.14% year-over-year to $37.0 billion; the TTM figure through Mar 2026 stood at $37.0 billion (up 6.14% YoY), while the FY2026 annual figure was $38.6 billion, up 10.4% from the prior year.
• Goodwill was $37.0 billion for Q1 2026 at Takeda Pharmaceutical, down from $37.4 billion in the prior quarter.
• In the past five years, Goodwill ranged from a high of $37.9 billion in Q1 2022 to a low of $33.2 billion in Q4 2022.
• Historically, Goodwill has averaged $36.3 billion across 5 years, with a median of $36.6 billion in 2025.
• The sharpest annual moves came in 2022 and 2025: Goodwill retreated 9.44% in 2022, then gained 6.56% in 2025.
• A 5-year view of Goodwill shows it stood at $33.2 billion in 2022, then gained by 4.14% to $34.6 billion in 2023, then climbed by 5.04% to $36.3 billion in 2024, then increased by 2.92% to $37.4 billion in 2025, then retreated by 0.92% to $37.0 billion in 2026.
• The last three Goodwill figures came in at $37.0 billion (Q1 2026), $37.4 billion (Q4 2025), and $36.9 billion (Q3 2025), per Business Quant data.